Reuters is reporting that the FDA’s Arthritis Advisory Board has unanimously recommended Amgen’s biosimilar of AbbVie’s Humira, ABP 501. The panel said that the drug was similar in safety and effectiveness to Humira for rheumatoid arthritis and plaque psoriasis, and it recommended that the biosimilar should also be approved for Crohn’s disease in adults and ulcerative colitis. (Reuters)
Toohey is the former president and CEO of the Semiconductor Industry Association, where he oversaw that industry’s federal advocacy, international trade and technology programs, as well as a veteran of PhRMA’s advocacy team.
Upsher-Smith has received the award four times in the past six years, and it was one of 12 DIANA award winners honored at the HAD’s 2016 Business and Leadership Conference held in Colorado Springs, Colo. on June 13.